CHUNLI MEDICAL Issues Proxy Form for 26 May 2026 AGM, Tables Eight Key Resolutions

Bulletin Express

Apr 30

Beijing Chunlizhengda Medical Instruments Co., Ltd. (CHUNLI MEDICAL, 01858) has released the proxy form for its 2025 Annual General Meeting (AGM), scheduled for 2:00 p.m. on Tuesday, 26 May 2026 at No. 10 Xinmi Xi Er Road, Southern District of Tongzhou Economic Development Zone, Tongzhou District, Beijing, PRC.

Shareholders may appoint the meeting chairman or another proxy to vote on the following matters:

1. Approval of the 2025 annual report and its summary. 2. Approval of the 2025 profit distribution plan. 3. Approval of the 2025 performance report of the independent non-executive directors. 4. Approval of the board of directors’ report for 2025. 5. Approval of the 2025 financial report. 6. Approval of directors’ remuneration for 2026. 7. Appointment of domestic, overseas and internal control auditors for 2026. 8. (Special resolution) Granting a general mandate to the board to repurchase the company’s H shares.

According to the notice, completed proxy forms and related authorization documents must reach the H-share registrar, Tricor Investor Services Limited (17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong), no later than 24 hours before the meeting. Proxy instructions marked “abstain” will be counted in the calculation of the required majority.

Further information on the resolutions is provided in the circular dated 29 April 2026. Personal identification will be required for shareholders or proxies attending the AGM.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1109462276"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1109462276\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1109462276?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-30 06:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1109462276","market":"us","top_or_hot":-1,"title":"CHUNLI MEDICAL Issues Proxy Form for 26 May 2026 AGM, Tables Eight Key Resolutions","media":"Bulletin Express","content":"<p>Beijing Chunlizhengda Medical Instruments Co., Ltd. (CHUNLI MEDICAL, 01858) has released the proxy form for its 2025 Annual General Meeting (AGM), scheduled for 2:00 p.m. on Tuesday, 26 May 2026 at No. 10 Xinmi Xi Er Road, Southern District of Tongzhou Economic Development Zone, Tongzhou District, Beijing, PRC.</p>\n<p>Shareholders may appoint the meeting chairman or another proxy to vote on the following matters:</p>\n<p>1. Approval of the 2025 annual report and its summary.  \n2. Approval of the 2025 profit distribution plan.  \n3. Approval of the 2025 performance report of the independent non-executive directors.  \n4. Approval of the board of directors’ report for 2025.  \n5. Approval of the 2025 financial report.  \n6. Approval of directors’ remuneration for 2026.  \n7. Appointment of domestic, overseas and internal control auditors for 2026.  \n8. (Special resolution) Granting a general mandate to the board to repurchase the company’s H shares.</p>\n<p>According to the notice, completed proxy forms and related authorization documents must reach the H-share registrar, Tricor Investor Services Limited (17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong), no later than 24 hours before the meeting. Proxy instructions marked “abstain” will be counted in the calculation of the required majority.</p>\n<p>Further information on the resolutions is provided in the circular dated 29 April 2026. Personal identification will be required for shareholders or proxies attending the AGM.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CHUNLI MEDICAL Issues Proxy Form for 26 May 2026 AGM, Tables Eight Key Resolutions</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCHUNLI MEDICAL Issues Proxy Form for 26 May 2026 AGM, Tables Eight Key Resolutions\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-30 06:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Beijing Chunlizhengda Medical Instruments Co., Ltd. (CHUNLI MEDICAL, 01858) has released the proxy form for its 2025 Annual General Meeting (AGM), scheduled for 2:00 p.m. on Tuesday, 26 May 2026 at No. 10 Xinmi Xi Er Road, Southern District of Tongzhou Economic Development Zone, Tongzhou District, Beijing, PRC.</p>\n<p>Shareholders may appoint the meeting chairman or another proxy to vote on the following matters:</p>\n<p>1. Approval of the 2025 annual report and its summary.  \n2. Approval of the 2025 profit distribution plan.  \n3. Approval of the 2025 performance report of the independent non-executive directors.  \n4. Approval of the board of directors’ report for 2025.  \n5. Approval of the 2025 financial report.  \n6. Approval of directors’ remuneration for 2026.  \n7. Appointment of domestic, overseas and internal control auditors for 2026.  \n8. (Special resolution) Granting a general mandate to the board to repurchase the company’s H shares.</p>\n<p>According to the notice, completed proxy forms and related authorization documents must reach the H-share registrar, Tricor Investor Services Limited (17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong), no later than 24 hours before the meeting. Proxy instructions marked “abstain” will be counted in the calculation of the required majority.</p>\n<p>Further information on the resolutions is provided in the circular dated 29 April 2026. Personal identification will be required for shareholders or proxies attending the AGM.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01858","symbol_name":"春立医疗","start_time":0,"source_url":"","article_id":"1109462276","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1109462276","pubTimestamp":1777501538,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Beijing Chunlizhengda Medical Instruments Co., Ltd. (CHUNLI MEDICAL, 01858) has released the proxy form for its 2025 Annual General Meeting (AGM), scheduled for 2:00 p.m. on Tuesday, 26 May 2026 at...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01858":"春立医疗"},"translate_title":"春立医疗就2026年5月26日股东周年大会发出代表委任表格，列出八项主要决议案","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01858":1},"content_text":"Beijing Chunlizhengda Medical Instruments Co., Ltd. (CHUNLI MEDICAL, 01858) has released the proxy form for its 2025 Annual General Meeting (AGM), scheduled for 2:00 p.m. on Tuesday, 26 May 2026 at No. 10 Xinmi Xi Er Road, Southern District of Tongzhou Economic Development Zone, Tongzhou District, Beijing, PRC.\nShareholders may appoint the meeting chairman or another proxy to vote on the following matters:\n1. Approval of the 2025 annual report and its summary.  \n2. Approval of the 2025 profit distribution plan.  \n3. Approval of the 2025 performance report of the independent non-executive directors.  \n4. Approval of the board of directors’ report for 2025.  \n5. Approval of the 2025 financial report.  \n6. Approval of directors’ remuneration for 2026.  \n7. Appointment of domestic, overseas and internal control auditors for 2026.  \n8. (Special resolution) Granting a general mandate to the board to repurchase the company’s H shares.\nAccording to the notice, completed proxy forms and related authorization documents must reach the H-share registrar, Tricor Investor Services Limited (17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong), no later than 24 hours before the meeting. Proxy instructions marked “abstain” will be counted in the calculation of the required majority.\nFurther information on the resolutions is provided in the circular dated 29 April 2026. Personal identification will be required for shareholders or proxies attending the AGM.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}